# 510(k) Summary: Device Modification— Roche cobas 6000 Series System

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence

# Submitter name, address, contact

Roche Diagnostics 9115 Hague Rd Indianapolis IN 46250 (317) 521-3723

Contact person: Kerwin Kaufman

Date prepared: January 23, 2006

# Device Name

Proprietary name: cobas 6000 Series system

Common names: Analyzer, Chemistry (Photometric,Discrete), for clinical use

Classification names: Discrete photometric chemistry analyzer for clinical use

# Device Description

The cobas 6000 Series system:

is fully automated, $\bullet$ is modular, is computerized, uses serum/plasma, urine, CSF, and supernatant sample types, performs in vitro quantitative and qualitative tests on a wide range of analytes, and performs photometric assays and ion-selective electrode measurements on a c 501 module as well as electrochemiluminescence (ECL) assays on an e 601 module.

The cobas 6000 system comprises the following hardware units, which can be combined in various combinations:

Control unit Core unit cu 150 c 501 module c 601 module

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Device Description (continued)

The control unit uses a graphical user interface to control all instrument functions, and is comprised of a printer, TFT monitor, keyboard and mouse and a personal computer using the Windows XP operating system.

The core unit is comprised of several components that manage conveyance of samples to each assigned analytical module. The actual composition of the core unit depends on the configuration of the analytical modules. The core unit comprises at least the sampling unit and one rack rotor as main components. Conveyor line(s) and a second rack rotor are possible extensions. Several other core unit components include the sample rack loader/unloader, a STAT port, a barcode reader (for racks and samples), a water supply and a system interface port.

The c 501 module comprises a photometric unit and an ISE unit (for ionselective electrode determinations). The photometric unit assays up to 600 in vitro tests per hour on a wide range of analytes. The main components of the c 501 module are a sampling system, a reagent system and a reaction disk system. The c 501 module also contains an integrated ISE unit, providing a potentiometric method for assaying sodium, potassium and chloride samples, processing up to 200 samples (600 tests) per hour.

The e 601 module is analytically identical to the Elecsys E170 MODULAR ANALYTICS immunoassay analyzer, which was cleared in a letter to file K961481 / A003. Hardware changes are only cosmetic (shape, color) or housing related (sample rack interface), and do not impact analytical properties or performance of the analyzer. The e 601 module is a muti-test immunoassay system with random access and with a capacity of up to 170 tests per hour. The main components of the e 601 module are a reagent area, a measurement area, a consumables area and a PreClean area.

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Intended use / Indications for use

The cobas 6000 series is a fully automated, random-access, softwarecontrolled system for immunoassay and photometric analysis intended for qualitative and quantitiative in vitro determinations using a wide variety of tests. It is optimized for high throughput workloads in the professional environment using a combination of ion selective electrodes (ISE), a photometric analysis unit and an immunoassay analysis module.

The cobas c501 analyzer is a fully automated, discrete clinical chemistry analyzer intended for the in vitro quantitative/ qualitative determination of analytes in body fluids.

The cobas e601 analyzer is a fully automated discrete immunoassay analyzer intended for the in vitro quantitative / qualitative determination of analytes in body fluids.

# Predicate Device

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Device   
modification,   
cobas 6000   
Series

The table below compares the modified device, cobas 6000 Series System to the current device, Roche/Hitachi MODULAR ANALYTICS System.

<table><tr><td>Topic</td><td>Roche/Hitachi MODULAR ANALYTICS System with MODULAR P and ISE Module (K953239 / A005) and MODULAR E170 (K961481 / A003)</td><td>cobas 6000 Series System with cobas e 501 and e 601 Analyzers (Modified Device)</td></tr><tr><td colspan="3">System Description Intended Use The MODULAR The cobas 6000 series is a</td></tr><tr><td></td><td>ANALYTICS for the Serum Work Area is a fully automated system for immunological, potentiometric and photometric analysis. The Hitachi MODULAR P is a fully automated, discrete clinical chemistry analyzer intended for the in vitro quantitative / qualitative determination of analytes in intended for the in vitro</td><td>fully automated, random- access, software-controlled system for immunoassay and photometric analysis intended for qualitative and quantitiative in vitro determinations using a wide variety of tests. It is optimized for high throughput workloads in the professional environment using a combination of ion</td></tr><tr><td>body fluids</td><td>body fluids. The Roche Elecsys E170 is a fully automated, discrete immunoassay analyzer intended for the in vitro quantitative / qualitative determination of analytes in clinical chemistry analyzer</td><td>selective electrodes (ISE), a photometric analysis unit and an immunoassay analysis module. The cobas c501 analyzer is a fully automated, discrete</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Device modification, cobas 6000 Series (continued)

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Roche/Hitachi MODULARANALYTICS System withMODULAR P and ISEModule (K953239 / A005)and MODULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas 6000 Series Systemwithcobas c 501 and e 601Analyzers(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>System Description (continued)</td></tr><tr><td rowspan=1 colspan=1>Intended Use(continued)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>The cobas e601 analyzer isa fully automated discreteimmunoassay analyzerintended for the in vitroquantitative / qualitativedetermination of analytesin body fluids.</td></tr><tr><td rowspan=1 colspan=1>Measurement principle</td><td rowspan=1 colspan=1>ISE Potentiometry(electrolytes)Absorbance Photometry(enzymes, substrates,proteins, DAT, TDM)ElectrochemiluminescenceImmunoassay method</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reaction modes</td><td rowspan=1 colspan=1>Endpoint, kinetic,potentiometric, electro-chemiluminescence</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Software SIMILARITIES</td></tr><tr><td rowspan=1 colspan=1>Software</td><td rowspan=1 colspan=1>MODULAR ANALYTICSSystem Software</td><td rowspan=1 colspan=1>cobas 6000 series SystemSoftware (modifiedMODULAR ANALYTICSsoftware)</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>Several analytical units withone PC and one core</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification  Roche cobas 6000 Series System, Continued

Device modification, cobas 6000 Series (continued)   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Rocbe/Hitachi MODULARANALYTICS System withMODULAR P and ISEModule (K953239 / A005)and MODULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas 6000 Series Systemwithcobas c 501 and e 601Analyzers(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>Software SIMILARITIES (continued)</td></tr><tr><td rowspan=1 colspan=1>Functions performed</td><td rowspan=1 colspan=1>Data input, sampleprocessing, resultcalculation, result reporting,quality control</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>PC (Controller Unit)functions</td><td rowspan=1 colspan=1>Data input (keyboard, disc),data output (screen, printer)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Core Unit functions</td><td rowspan=1 colspan=1>Real time database, datainput and output (via HOSTcommunication), control ofsample conveyer</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analytical Unit(s)functions</td><td rowspan=1 colspan=1>Control of analytic processes(pipetting, incubation,detection)Primary Signal processing</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Data storage</td><td rowspan=1 colspan=1>Real time database in Coreunit (storage of System andApplication parameters,Calibration Data , QC Data,Sample results, Alarmhistory)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Result calculation</td><td rowspan=1 colspan=1>Automated measuring ofsignal for kinetic andendpoint methods accordingto cycle time and automatedcalculation of concentrationsvia calibration curve</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>User management</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Flagging of errors</td><td rowspan=1 colspan=1>Available</td><td rowspan=1 colspan=1>Available</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Device modification, cobas 6000 Series (continued)

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Roche/Hitachi MODULARANALYTICS System withMODULAR P and ISEModule (K953239 / A005)and MODULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas 6000 Series Systemwithcobas c 501 and e 601Analyzers(Modified Device)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>Software DIFFERENCES</td></tr><tr><td rowspan=1 colspan=1>Units controlled</td><td rowspan=1 colspan=1>MODULAR P analyzer, ISEanalyzer, MODULAR Danalyzer, E170 analyzer</td><td rowspan=1 colspan=1>cobas c501 and cobase601 analyzers</td></tr><tr><td rowspan=1 colspan=1>HbA1c measurement oncobas c501</td><td rowspan=1 colspan=1>Hemolysate application asseparate assays</td><td rowspan=1 colspan=1>Hemolysate application asone assay</td></tr><tr><td rowspan=1 colspan=1>Initial cassette volumecheck (ICVC) forreagent pipetting oncobas c501</td><td rowspan=1 colspan=1>Not available</td><td rowspan=1 colspan=1>Available</td></tr><tr><td rowspan=1 colspan=1>Clot detection</td><td rowspan=1 colspan=1>Not available onMODULAR P butavailable on E170</td><td rowspan=1 colspan=1>Available on both cobasc501 and e601 analyzers</td></tr><tr><td rowspan=1 colspan=1>Sample carry overevasion from cobasc501 module to the e601module</td><td rowspan=1 colspan=1>One feature implemented toprevent sample carry overfrom MODULAR P to E170</td><td rowspan=1 colspan=1>Additional featureimplemented to preventsample carry over</td></tr><tr><td rowspan=1 colspan=1>Data concept(Application parameter,calibrator, control valuetransfer) for cobas c501and e601 modules</td><td rowspan=1 colspan=1>No electronic transfer</td><td rowspan=1 colspan=1>Electronic transfer possible(user must accept transferbefore parameters applied)</td></tr><tr><td rowspan=1 colspan=1>QC concept for cobasc501 and e601 modules</td><td rowspan=1 colspan=1>Auto QC not available</td><td rowspan=1 colspan=1>Auto QC implemented</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

Device Modification, cobas c 501

The table below compares the similarities and differences of the cobas c 501 analyzer to the Hitachi MODULAR P analyzer.

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Hitachi MODULAR P(K953239 / A005)</td><td rowspan=1 colspan=1>cobas c 501 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>Analyzer Features</td></tr><tr><td rowspan=1 colspan=1>Throughput</td><td rowspan=1 colspan=1>Max. 800 tests per hourwithout ISE</td><td rowspan=1 colspan=1>Max. 600 tests per hourwithout ISE</td></tr><tr><td rowspan=1 colspan=1>Analyzer size</td><td rowspan=1 colspan=1>Stand alone module ormultiple modules linked toform one unit</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Sample Handling</td></tr><tr><td rowspan=1 colspan=1>Typical sample volumes</td><td rowspan=1 colspan=1>2-35 μL</td><td rowspan=1 colspan=1>1.0 - 35 μL</td></tr><tr><td rowspan=1 colspan=1>Sample types</td><td rowspan=1 colspan=1>Serum, plasma, urine, CSFand other depending on thechemistry test</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample handling system</td><td rowspan=1 colspan=1>Input of samples via coreinput buffer using universalsample racks</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample capacity onboard</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>Sample identification</td><td rowspan=1 colspan=1>Barcode</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Reagent Handling</td></tr><tr><td rowspan=1 colspan=1>Reagent volume</td><td rowspan=1 colspan=1>20-270 μL</td><td rowspan=1 colspan=1>5-180 μL</td></tr><tr><td rowspan=1 colspan=1>Reagent container(electrolytes)</td><td rowspan=1 colspan=1>Plastic bottles closed viascrewcaps</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent container (non-electrolytes)</td><td rowspan=1 colspan=1>Plastic bottles closed viascrewcaps</td><td rowspan=1 colspan=1>Plastic bottles closed viapierceable screwcaps withmodified bottle material</td></tr><tr><td rowspan=1 colspan=1>Reagent access</td><td rowspan=1 colspan=1>Manual opening of reagentbottle prior to placementonboard</td><td rowspan=1 colspan=1>Reagent cassette capspierced onboard by theinstrument</td></tr><tr><td rowspan=1 colspan=1>Onboard storagetemperature</td><td rowspan=1 colspan=1>Refrigerated 5-12 °C</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

cobas c 501 (continued)

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=2>Hitachi MODULAR P(K953239 / A005)</td><td rowspan=1 colspan=1>cobas c 501 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=1>Reagent Bottle /Cassette identification</td><td rowspan=1 colspan=2>Barcode</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On board reagentstorage capacity</td><td rowspan=1 colspan=2>44 rotor channels on 2 rotorsto run 44 reagent kits inparallel</td><td rowspan=1 colspan=1>60 rotor channels on 1rotor to run 60 reagent kitsin parallel</td></tr><tr><td rowspan=1 colspan=1>System cycle time</td><td rowspan=1 colspan=2>18 sec</td><td rowspan=1 colspan=1>8 sec</td></tr><tr><td rowspan=1 colspan=1>Reagent mixing</td><td rowspan=1 colspan=2>Stirring</td><td rowspan=1 colspan=1>Ultrasonic</td></tr><tr><td rowspan=1 colspan=1>Auto rerun</td><td rowspan=1 colspan=2>Available</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=4>Pipetting System</td></tr><tr><td rowspan=1 colspan=1>Sample and reagentSyringes</td><td rowspan=1 colspan=1>XY robotic</td><td rowspan=1 colspan=2>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent probes</td><td rowspan=1 colspan=1>2 polished steel probes</td><td rowspan=1 colspan=2>2 polished steel probes withmodified design</td></tr><tr><td rowspan=1 colspan=1>Sample probes</td><td rowspan=1 colspan=1>1 polished steel probe</td><td rowspan=1 colspan=2>1 polished steel probe withmodified design</td></tr><tr><td rowspan=1 colspan=1>Probe cleaning</td><td rowspan=1 colspan=1>Automatic for all probes</td><td rowspan=1 colspan=2>Same</td></tr><tr><td rowspan=1 colspan=1>Liquid level detection</td><td rowspan=1 colspan=1>Electrostatic for sample andreagents</td><td rowspan=1 colspan=2>Electrostatic for sampleInitial Cassette VolumeCheck (ICVC) and bubbledetection for reagent</td></tr><tr><td rowspan=1 colspan=1>Clot detection</td><td rowspan=1 colspan=1>Not available</td><td rowspan=1 colspan=2>Provided</td></tr><tr><td rowspan=1 colspan=4>Test Reaction Chamber</td></tr><tr><td rowspan=1 colspan=1>Temperature control</td><td rowspan=1 colspan=2>Circulating water bath at37°C.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cuvettes</td><td rowspan=1 colspan=2>Multiple use</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

cobas e 501 (continued)   

<table><tr><td rowspan=1 colspan=2>Topic</td><td rowspan=1 colspan=2>Hitachi MODULAR P(K953239 / A005)</td><td rowspan=1 colspan=1>cobas c 501 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=5>ISE Module</td></tr><tr><td rowspan=1 colspan=2>ISE module</td><td rowspan=1 colspan=2>Separate ISE Module(K953239 / A005) integratedinto MODULARANALYTICS System</td><td rowspan=1 colspan=1>Module integrated intocobas c 501 analyzer; newhardware design withmodified pipetting schemefor sample and reagent</td></tr><tr><td rowspan=1 colspan=2>Ion selective electrodes(ISEs)</td><td rowspan=1 colspan=2>Potentiometric chloride,potassium, sodium andreference electrodes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>ISE throughput</td><td rowspan=1 colspan=2>Up to 900 tests/hour</td><td rowspan=1 colspan=1>Up to 600 tests/hour</td></tr><tr><td rowspan=1 colspan=5>Detection Information</td></tr><tr><td rowspan=1 colspan=2>Spectrophotometer</td><td rowspan=1 colspan=2>Gradient photometer withdiscrete photodiodes in fixedarray</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Light source</td><td rowspan=1 colspan=2>Tungsten/halogen</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Light path</td><td rowspan=1 colspan=2>0.50 cm</td><td rowspan=1 colspan=1>0.56 cm</td></tr><tr><td rowspan=1 colspan=2>Measuring unit</td><td rowspan=1 colspan=2>1</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Wavelengths</td><td rowspan=1 colspan=2>340, 376, 415, 450, 480,505, 546, 570, 600, 660,700, 800 nm</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=5>Calibration and quality control</td></tr><tr><td rowspan=1 colspan=2>Calibrators</td><td rowspan=1 colspan=2>Multiple use</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Calibration modes</td><td rowspan=1 colspan=2>Linear, nonlinear</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Calibration / on boardstability</td><td rowspan=1 colspan=2>Typically each lot or 4weeks for same reagent onboard</td><td rowspan=1 colspan=1>Typically each lot or 12weeks for same reagent onboard</td></tr><tr><td rowspan=1 colspan=2>Control storage oninstrument</td><td rowspan=1 colspan=2>No</td><td rowspan=1 colspan=1>In analyzer remote bufferarea at ambienttemperature</td></tr><tr><td rowspan=1 colspan=2>Calibrator / controlvalue transfer</td><td rowspan=1 colspan=2>Via Barcode Transfer Sheet,application disk or manualentry</td><td rowspan=1 colspan=1>Via remote transfer orCD-ROM</td></tr><tr><td rowspan=1 colspan=2>Internal qualitymanagement system</td><td rowspan=1 colspan=2>Available to monitor andvalidate test results</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification- Roche cobas 6000 Series System, Continued

cobas c 501 (continued)   

<table><tr><td rowspan=1 colspan=3>Interfaces</td></tr><tr><td rowspan=1 colspan=1>Host Interface</td><td rowspan=1 colspan=1>RS232C bi-directional</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Printer</td><td rowspan=1 colspan=1>Dot matrix</td><td rowspan=1 colspan=1>Laser</td></tr><tr><td rowspan=1 colspan=1>Display</td><td rowspan=1 colspan=1>Keyboard + touch-screen</td><td rowspan=1 colspan=1>SameOptional use of mouse</td></tr></table>

The table below compares the cobas e 601 analyzer to the Elecsys MODULAR E170 analyzer.

Device Modification, cobas e 601   

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys MOdULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas e 601 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>Analyzer Features</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Intended to be used for the invitro quantitative andqualitative analysis ofanalytes in body fluids</td><td rowspan=1 colspan=1>The cobas e601 analyzer isa fully automated discreteimmunoassay analyzerintended for the in vitroquantitative / qualitativedetermination of analytesin body fluids.</td></tr><tr><td rowspan=1 colspan=1>Indication for use</td><td rowspan=1 colspan=1>For professional use only</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Operating principle</td><td rowspan=1 colspan=1>ElectrochemiluminescenceImmunoassay method</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Workflow principle</td><td rowspan=1 colspan=1>Random access or batch</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analyzer size</td><td rowspan=1 colspan=1>Floor analyzer</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Maximum Throughput</td><td rowspan=1 colspan=1>170 tests/hour per module</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification Roche cobas 6000 Series System, Continued

cobas e 601 (continued)

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys MODULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas e 601 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>1 stand alone module or 2-4modules linked together inRoche MODULARAnalytics System</td><td rowspan=1 colspan=1>1 stand alone module or upto 2 modules linkedtogether in the cobas 6000Series System</td></tr><tr><td rowspan=1 colspan=3>Sample</td></tr><tr><td rowspan=1 colspan=1>Sample material</td><td rowspan=1 colspan=1>Serum and Plasma</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample input</td><td rowspan=1 colspan=1>Via sample racks</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Positive Identification</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Reagents</td></tr><tr><td rowspan=1 colspan=1>Reagent Kits</td><td rowspan=1 colspan=1>Assay RackPack</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>No. of Channels</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-board Temperature</td><td rowspan=1 colspan=1>18-22°C</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>System reagents</td><td rowspan=1 colspan=1>ProCell, CleanCell,SysClean, PreClean,*ProbeWash** used for specific assays</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Sample Pipetting</td></tr><tr><td rowspan=1 colspan=1>Liquid level detection</td><td rowspan=1 colspan=1>Electrostatic sensing</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Clot detection</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Pipetting device</td><td rowspan=1 colspan=1>Disposable tip</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Reagent Pipetting</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Pipetting device</td><td rowspan=1 colspan=1>Steel probe</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Incubation</td></tr><tr><td rowspan=1 colspan=1>Temperature</td><td rowspan=1 colspan=1>37°C</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Timing</td><td rowspan=1 colspan=1>18 minutes ** specific assays: 17 minutes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Detection</td></tr><tr><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>ECL unit(sipper, cell, PMT)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Channels</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary: Device Modification— Roche cobas 6000 Series System, Continued

cobas e 601 (continued)

<table><tr><td rowspan=1 colspan=1>Topic</td><td rowspan=1 colspan=1>Elecsys MODULAR E170(K961481 / A003)</td><td rowspan=1 colspan=1>cobas e 601 Analyzer(Modified Device)</td></tr><tr><td rowspan=1 colspan=3>Calibration / Quality Control</td></tr><tr><td rowspan=1 colspan=1>Calibration mode</td><td rowspan=1 colspan=1>2-point calibration</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrators and Controls</td><td rowspan=1 colspan=1>CalSets, CalChecks andControls</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration intervalswith each new lot</td><td rowspan=1 colspan=1>Mandatory</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration stability</td><td rowspan=1 colspan=1>4 weeks</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Dilution</td></tr><tr><td rowspan=1 colspan=1>On-board</td><td rowspan=1 colspan=1>Optional</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Disposables</td></tr><tr><td rowspan=1 colspan=1>cYanmaGnntaYellob</td><td rowspan=1 colspan=1>Tips</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Assay cups</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Failsafe</td></tr><tr><td rowspan=1 colspan=1>Failsafe Concept</td><td rowspan=1 colspan=1>Internal QualityManagement System onmultiple levels:-Control and verification ofinstrument operation-Data input control-Validation of results-Corresponding Alarm andFlag System</td><td rowspan=1 colspan=1>Same</td></tr></table>

Kerwin Kaufman, MBA, MT(ASCP)   
Regulatory Affairs Principal   
Roche Diagnostics   
9115 Hague Road   
Indianapolis, IN 46250

Re: k060373 Trade/Device Name: cobas 6000 Series System Regulation Number: 21 CFR§862.1600 Regulation Name: Potassium test system Regulatory Class: Class II Product Code: CEM, CGZ, CZW, DJG, JFJ, JGS, KNK, LDP, JJE Dated: February 10, 2006 Received: February 13, 2006

Dear Mr. Kaufman;

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate coerce prior to May 28, 1976, the enactment date of the Medical Device Amendments,  to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The lnts proish ceet al at devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2-

This letter will alow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/d9ff5569c5a1e65772fbc3bca167f16a4cad60bcadd834d554980090a10736be.jpg)

Alberto Gutierez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (if known): K060373

Device Name: cobas 6000 Series System

Indications For Use:

The cobas 6000 series is a fully automated, random-access, software-controlled system for immunoassay and photometric analysis intended for qualitative and quantitiative in vitro determinations using a wide variety of tests. It is optimized for high throughput workloads in the professional environment using a combination of ion selective electrodes (ISE), a photometric analysis unit and an immunoassay analysis module.

The cobas c501 analyzer is a fully automated, discrete clinical chemistry analyzer intended for the in vitro quantitative/ qualitative determination of analytes in body fluids.

The cobas e601 analyzer is a fully automated discrete immunoassay analyzer intended for the in vitro quantitative / qualitative determination of analytes in body fluids.

The $\propto$ -Amylase EPS ver.2 assay is an in vitro test for the quantitative determination of $\alpha$ - Amylase in serum, plasma and urine on Roche/Hitachi cobas c systems. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis.

The Uric Acid ver.2 assay is an in vitro test for the quantitative determination of uric acid in human serum, plasma and urine on Roche/Hitachi cobas c systems. Uric acid measurements are used in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs.

(21 CFR 807 Subpart C)

# Indications for Use

510(k) Number (if known): K060373

Device Name: cobas 6000 Series System

Indications For Use: (CONTINUED)

The Tina-quant Complement C3c ver.2 assay is an in vitro test for the quantitative determination of Complement C3c in human serum and plasma on Roche/Hitachi cobas c systems. Measurement of complement C3c aids in the diagnosis of immunologic disorders, especially those associated with deficiencies of complement components.

The ISE module of the Roche/Hitachi cobas c systems is intended for the quantitative determination of sodium, potassium and chloride in serum, plasma or urine using ionselective electrodes. Measurements obtained by this device are used in the diagnosis and treatment of diseases or conditions involving electrolyte imbalance.

The Acetaminophen assay is an in vitro test for the quantitative determination of toxic levels of acetaminophen in serum and plasma on Roche/Hitachi cobas c systems. Measurements obtained by this device are used in the diagnosis and treatment of acetaminophen overdose.

The Opiates II assay is an in vitro diagnostic test for the qualitative and semiquantitative detection of morphine and its metabolites in human urine on Roche/Hitachi cobas c systems at cutoff concentrations of 300 and $2 0 0 0 ~ \mathrm { { n g / m L } }$ .Semiquantitative test results may be obtained that permit laboratories to assess assay performance as part of a quality control program. Opiates II provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose.

<table><tr><td>Prescription Use XXX</td><td>AND/OR</td><td>Over-The-Counter Use</td></tr><tr><td></td><td></td><td></td></tr><tr><td>(Part 21 CFR 801 Subpart D)</td><td></td><td>(21 CFR 807 Subpart C)</td></tr><tr><td></td><td></td><td></td></tr></table>